ReutersNovartis says lung cancer drug Zykadia gains EU approvalReutersZURICH Swiss drugmaker Novartis said European health regulators have approved a drug for advanced lung cancer that is intended to treat patients with a specific genetic mutation. Zykadia, or ceritinib, is from a new class of medicines known as ALK ...Novartis: Zykadia gains EU approval - Quick FactsRTT NewsNovartis lung cancer drug Zykadia® gains EU approval, providing new therapy ...Yahoo Finance UKNovartis lung cancer drug Zykadia(R) gains EU approval, providing new therapy ...MarketWatchall 4 news articles »
Novartis says lung cancer drug Zykadia gains EU approval
Rating: 4.5
Diposkan Oleh: Unknown
